Join
Live feed
·
PRReleasevia Quantisnow
Takeda Pharmaceutical Company Limited logo

Nimbus Therapeutics Announces Closing of Takeda's Acquisition of TYK2 Subsidiary

ByQuantisnow·Wall Street's wire, on your screen.
TAK· Takeda Pharmaceutical Company Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TAK (Takeda Pharmaceutical Company Limited) and more on Quantisnow.

Nimbus Therapeutics Announces Closing of Takeda's Acquisition of TYK2 Subsidiary | Quantisnow